Atlas Trials

Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-

Clinical trial NCT06937996 · RECRUITING

Trial details

NCT number
NCT06937996
Sponsor
Englewood Hospital and Medical Center
Status
RECRUITING
Study type
OBSERVATIONAL
Pancreatic Cancer Non-resectable
Start date
2025-05-13
Primary completion
2035-05-31
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.